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The ubiquitous coronavirus 2019 (COVID-19) pandemic has required healthcare providers across all disciplines to rapidly adapt to public health guidelines
to reduce risk while maintaining quality of care. Electroconvulsive therapy
(ECT), which involves an aerosol-generating procedure from manual ventilation with a bag mask valve while under anesthesia, has undergone drastic
practice changes in order to minimize disruption of treatment in the midst of
COVID-19. In this paper, we provide a consensus statement on the clinical practice changes in ECT specific to older adults based on expert group discussions of
ECT practitioners across the country and a systematic review of the literature.
There is a universal consensus that ECT is an essential treatment of severe mental illness. In addition, there is a clear consensus on what modifications are
imperative to ensure continued delivery of ECT in a manner that is safe for
patients and staff, while maintaining the viability of ECT services. Approaches
to modifications in ECT to address infection control, altered ECT procedures,
and adjusting ECT operations are almost uniform across the globe. With modified ECT procedures, it is possible to continue to meet the needs of older patients
while mitigating risk of transmission to this vulnerable population. (Am J Geriatr Psychiatry 2020; 28:1133−1145)
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INTRODUCTION

W

ith over 3.8 million cases in the United States
alone,1 the coronavirus 2019 disease (COVID19) caused by the novel coronavirus (SARS-CoV-2)
has had a profound impact on health care systems.
Because COVID-19 primarily presents as a respiratory illness and is transmitted through respiratory
droplets, great care must be taken to reduce the risk
of transmission during as electroconvulsive therapy
(ECT), which involves an aerosol-generating procedure from manual ventilation with a bag mask valve
while under anesthesia. The danger of ECT practice
during COVID-19 is compounded as patients who
undergo ECT are often older, frail, and at higher risk
than the general population. ECT is deemed an essential procedure by the American Psychiatric Association2 and drastic changes to ECT practices have been
necessary to mitigate risk for both patients and staff
while continuing to provide essential care.
For the geriatric population with severe depression
or psychosis who are highly burdened by psychiatric
symptomatology, ECT is an important and necessary
treatment. Data have shown that ECT is safe in older
adults despite medical comorbidities and is highly
effective in treating severe psychiatric illnesses such
as major depressive disorder, psychosis, mania, and
behavioral symptoms of dementia.3,4 Disruption in
the acute course of ECT in the absence of adverse
events would be harmful for older patients, potentially precipitating clinical decline.
Continuing safe administration of ECT to those
who need it while at the same time maintaining safety
for patients and staff presents an extraordinary challenge in clinical practice. In this paper we describe
modiﬁcations in ECT practices due to the COVID-19
pandemic based on expert consensus. The aim is to
help guide ECT clinicians in continuing to provide
ECT in a manner that is safe for patients and staff
while still preserving public health efforts to mitigate
and avoid infection spread.

METHODS
The development of this expert consensus statement involved the following steps: 1) topic selection;
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2) expert group discussion; and 3) systematic review
of literature.
Topic Selection
The focus of this paper is on the impact of COVID19 on ECT practices. Questions have arisen regarding
what modiﬁcations are needed to administer ECT in
a manner that is safe for both patients and staff,
within the available resources, and consistent with
good clinical practice. With such rapidly evolving
information, a consensus statement will consolidate
and disseminate current knowledge and provide
guidance to ECT practitioners and stakeholders.
Expert Group Discussion
The expert group is comprised of ECT experts
involved in the conduct of ECT-AD (A Randomized
Controlled Trial of Electroconvulsive Therapy plus
Usual Care versus Simulated-ECT plus Usual Care
for the Acute Management of Severe Agitation in Alzheimer's Dementia), an NIH-funded multisite clinical
trial of ECT for the treatment of severe agitation and
aggression in dementia. The authors serve as site PIs
(ML, AH, LN, MM, GP, BF), site co-investigators (SS,
SS), and project manager (HH), and have expertise in
psychiatry, geriatric psychiatry, and ECT clinical
administration and research. The conception, design,
and content of the manuscript were discussed during
weekly ECT-AD meetings from March thru May
2020. In-depth discussions were held regarding modiﬁcations that were being implemented at each of the
sites. In addition, an email question ''Are there any
changes to your ECT practice speciﬁc to geriatric
patients?'' was sent out to the International Society for
ECT and Neurostimulation listserv and responses
were compiled.
Systematic Review of Literature
The literature was searched by a medical librarian
for ECT or neurostimulation combined with COVID19. The search strategies were created using a combination of keywords and standardized index terms.
Searches were run in May 2020 in Google Scholar,
Ovid EBM Reviews, Ovid Embase (1974+), Ovid
Medline (1946+ including epub ahead of print, in-process & other non-indexed citations), Ovid PsycINFO

Am J Geriatr Psychiatry 28:11, November 2020

Lapid et al.
(1806+), Scopus (1970+), and Web of Science (1975+).
Results were limited to English citations from 2019+.
All results were exported to Endnote where obvious
duplicates were removed leaving 37 citations. Search
strategies are provided in the appendix. Two authors
(ML, SS) independently reviewed titles and abstracts
to select relevant studies, and disagreements were
resolved by consensus.

RESULTS
Results from ECT-AD discussions, insights from
International Society for ECT and Neurostimulation
members, and information from the systematic
review are collated and described below.
Systematic Review
Of 37 articles identiﬁed from the search, 11 met
inclusion criteria and were included in the review,
reported in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses ﬂow diagram.
(Fig. 1) The articles summarized in Table 1 include
four from the United States and Canada, four from
outside the United States, and three statements and
guidelines from professional associations.

DISCUSSION
Based on the expert group discussions and systematic review of the literature, there is a clear universal
agreement that ECT is an essential treatment that
should continue to be provided even during this pandemic. There is a clear consensus regarding the modiﬁcations that are essential to ensure that providing
ECT care is safe for patients and staff. There are also
changes to care processes and workﬂow that are common to all ECT practices. (Fig. 2) Despite the clear
consensus on current standards in ECT practice, there
is a lack of literature speciﬁc to older adults. The following recommendations represent a consolidation of
the expert group discussions, results of the systematic
review, and incorporation of considerations speciﬁc
to treating older adults with ECT in the current pandemic environment.
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INFECTION PREVENTION AND CONTROL
MEASURES
Based on the assumption that any patient is
potentially infected or a carrier of COVID-19, ECT
practices must follow standard, contact, and airborne precautions, as well as eye protection measures. Personal protective equipment protects
health care workers, sanitation and disinfection
practices reduce the risk of viral transmission, and
clustering of ECT patients can help prevent cross
contamination.
PPE
The use of PPE is imperative for staff protection, in
order to reduce the spread of COVID-19 through
patient contact. All health care personnel involved in
the administration of ECT are required to wear N95
respirators, which require prior ﬁt testing and education for N95 respirator use. A procedure mask can be
worn over the N95 respirator as an additional precaution if prolonged or repeated use is anticipated. In
addition to N95 respirators and procedure masks,
goggles, eye shields, or face shields have been added
to standard PPE to further prevent contact with
potentially infected droplets. Gloves are required,
and some use double gloves and replace the outer
gloves after each patient in order to prevent cross contamination between patients. Gowns are standard
and changed at varying times, although not required
in some institutions.
While protecting health care personnel during ECT
is paramount, the widespread shortage of proper PPE
has presented extensive obstacles to this goal. Policies
and guidelines on PPE are institution-speciﬁc and
evolving based on PPE availability. In ECT facilities
with adequate PPE resources, staff in the screening
area, waiting room, preparation or IV room, and
recovery room are also ﬁtted with N95 respirators. A
lack of surplus in most locations requires staff to be
assigned one set of PPE, and to reuse as appropriate.
Maintenance of N95 respirators is the responsibility
of individual staff, and the N95 respirators can be
kept in the ECT facility for reuse in individual,
labelled bags. Like the N95 respirators, other protective equipment such as procedure masks, goggles,
eye shields, or face shields also often need to be
reused due to supply shortages. Gowns and head
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FIGURE 1. PRISMA 2009 flow diagram. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.

coverings however should be disposed of at the end
of each day. Gloves are not reused. Every personnel
must be trained in proper donning (putting on) and
dofﬁng (taking off), as well as PPE disposal. In general ECT clinics are restricting or completely banning
the presence of non-essential personnel in the treatment area to maximize the preservation of PPE for
essential staff.
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Sanitation and Disinfection
The SARS-CoV-2 virus has been shown to survive
in aerosols and on surfaces for many days.5 The need
for environmental cleaning and decontamination
lowers the risk of viral transmission. Treatment rooms
are cleaned thoroughly after each treatment day, by
housekeeping or facility staff. However, to protect

Am J Geriatr Psychiatry 28:11, November 2020
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TABLE 1. Summary of Relevant United States and International Literature on ECT Practice Changes Due to COVID-19.
United States/Canada
Author, Year

Type of Article

Bryson and Aloysi,
202011US

Commentary

Group/Specialty

Aim/Purpose

Icahn School of Medicine at To describe ECT strategies
Mount Sinai
during the first 4 weeks of
Anesthesiology,
the SARS-CoV-2 outbreak
Psychiatry
in New York City.

ECT Practice Modifications


















Burhan et al, 202012
Canada

Reflection

Parkwood Institute-Mental
Health Care Building, an
academic site of Western
University in London
Ontario Canada.

To describe approach of a
rigorous patient prioritization process for selection
of ECT patients.











Espinoza et al, 202013
United States

Editorial
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UCLA, Medical University of To emphasize ECT as an
South Carolina, Medical
essential treatment.
College of Georgia,
Augusta University
Psychiatry

Consider every patient as exposed and potentially contagious.
Twice daily temperature and assessment of respiratory symptoms.
If febrile or with symptoms, defer ECT until second nasal swab negative.
Only treat the most critically ill.
Move ECT from post-anesthesia care unit (PACU) to negative pressure
operating room (OR).
No intubation or use of laryngeal mask airway (LMA), use standard bag-valvemask (BMV).
Use breathing circuit filter (BCF) with filter retention efficiency for airborne
particles.
Mask kept on patient’s face during passive exhalation and surgical mask over
the nose and mouth all other times.
Only essential members in treatment room.
N95 mask, face shield and non-porous gown and double gloves.
Same N95 respirator and gowns per day, but gloves changed between patients.
Anesthesiologist changes gowns for each patient.
Proper donning and doffing of personal protective equipment (PPE).
Patients brought to OR wearing surgical mask, removed only during positive
pressure ventilation.
Patients recover in OR.
Allow time for full circulation of room atmosphere prior to next patient.
All equipment cleaned with hydrogen peroxide disinfectant wipes between
each case.
Rigorous colored prioritization process modeled after ISEN recommendations.
Red (emergent), orange (highly urgent), yellow (urgent, can wait for up to 4
weeks), green (clinically monitored, provide quick access if the acuity
changes), and gray (stable long term, can be re-referred for new episode of
illness).
Informed consent process revised to add risk of infection.
ECT room modified to provide negative pressure and allow optimum air
circulation between patients.
Full PPE for staff, changed between patients.
COVID-19 screen prior to ECT, if positive, test with PCR4.
COVID-19 positive requires infectious disease and pandemic management
team consultation.
ECT started or re-started for red and orange zone within 1 week of initiating
the process.
Education is the first step in understanding ECT as an essential treatment.
Modifications to keep ECT service viable will vary at the local level.
Logistical changes and the process by which these changes are undertaken are
important.
Identifying key stakeholders will support access to continued ECT services.
Limiting new ECT and less frequent maintenance ECT may conserve resources.
ECT is lifesaving and should not be stopped completely in a discriminatory
fashion.

United States/Canada
Author, Year

Type of Article

Flexman et al, 2020

14

Consensus
statement

Group/Specialty

Aim/Purpose

Society for Neuroscience in To provide advice for neuroAnesthesiology and Critianesthesia clinical praccal Care (SNACC)
tice, including ECT.

ECT Practice Modifications













Test each patient before procedure.
ECT only for asymptomatic.
No ECT if COVID-19 positive.
If asymptomatic and tests positive but remains asymptomatic, proceed only if
testing 14 days later is negative, and if ECT is life-saving.
ECT in a negative pressure single airborne suite, utilize full PPE, restrict
personnel, careful disinfection, 30 minutes between patients.
Glycopyrrolate to minimize hypersalivation.
Remifentanil to reduce coughing on emergence, and lidocaine after seizure.
Avoid BMV if possible.
Induction agents for best seizure quality include ketamine, etomidate, and
methohexital.
Careful preoxygenation before induction of anesthesia when BMV is
minimized, consider apneic oxygenation.
Consider LMA when hyperventilation is required.
Patients should be masked in recovery.

International
Author, Year

Type of Article
10

Braithwaite, 2020
United Kingdom

Case report

Group/Specialty
Psychiatry

Aim/Purpose
To describe successful ECT in a 67-year
old male with life threatening severe
major depression with catatonia, who
was positive for SARS-CoV-2 with active
symptoms and radiological evidence of
pneumonitis.

ECT Practice Modifications
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Colbert, 202015
Ireland

Images in Clinical
ECT

Psychiatry

To illustrate visually the PPE ensemble
worn by members of the ECT team,
including gowns, headgear, masks, goggles and gloves.






Sienaert, 20209
Belgium

Perspective

KU Leuven, Academic Center for
ECT and

To provide a perspective on the essential
nature of ECT and describe measures to




6 bitemporal ECT twice weekly.
Positive-pressure emergency OR.
Four professionals - anesthesiologist, anesthesiology assistant, psychiatrist
and psychiatric nurse.
N99 respirator, cap, visor, gown, apron, shoe covers, three pairs of gloves.
Thorough disinfection of theatre and all equipment before next case.
Anesthesia induction with propofol, muscle relaxation with
suxamethonium, inhibition of secretions with glycopyrrolate.
4 of 6 ECT − avoided BMV by using O2 via mask alone
ECT Three and five - videolaryngoscopic intubation, followed by 20
minutes of inhaled sevoflurane and mechanical ventilation, after which
suxamethonium was given and ECT was delivered.
Psychiatrist was only present to deliver ECT, but was outside the treatment
room for intubation and extubation.
Successful outcome, catatonia and depression resolved after 6 ECT.
ECT practitioners need to liaise with anesthesia colleagues for a safe ECT
environment.
PPE is demonstrated in a picture.
Protocols should follow best practices.
PPE conservation should be considered in clinical decision-making
processes.
Psychiatrists review ECT needs with patients and families.
Close follow-up if maintenance ECT (M-ECT) is withheld or delayed.
(continued on next page)
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TABLE 1. (continued)
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TABLE 1. (continued)
International
Author, Year

Type of Article

Group/Specialty
Neuromodulation
(AcCENT), Center
of anatomical sciences and education UHasselt,
Department of
infection control,
Department of
Anesthesiology

Aim/Purpose
guide practitioners in safe
administration of ECT.

ECT Practice Modifications
















Tor, 202016
Singapore

Commentary

Department of Mood To describe ECT challenges in Singapore
and Anxiety, West
and describe ECT modifications to adapt
Zone, Institute of
to COVID-19 environment.
Mental Health
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Rescue ECT protocol for signs of relapse based on monitoring and rating
scales via televisits.
Temporary closure of day hospitals for persons 65 years and older
prevented nursing home residents to get M-ECT. Weekly ECT team
meetings reviewed these cases and rescue ECT was applied as needed.
Nasopharyngeal swab for PCR testing obtained a day before ECT.
For inpatients, daily monitoring for fever, coughing and dyspnea, and PCRtesting weekly.
For outpatients, PCR testing obtained a day before ECT.
If positive PCR-test, ECT still given but patients were treated last.
Rigorous cleaning, adequate ventilation with air flow of 5 air changes per
hour, disinfection of devices and surfaces with chlorine solution.
Minimum personnel in treatment room, including nurse, psychiatrist,
anesthesiologist and assistant-anesthesiologist.
PPE included two-respirator and gown (worn for whole day), eye
protection, gloves (changed according to WHO indication).
Glycopyrrolate used routinely.
BMV avoided, and pre-oxygenation at 5LPM via mask is used instead.
Re-allocation of resources required redeployment of staff to other tasks.
Weekly reassessment of readmission and rescue ECT processes.
Concludes with recommendations for ECT clinics to cooperate locally or
regionally to ensure availability of essential ECT to older adults and other
vulnerable populations.
ECT identified as essential service.
Full PPE (N95 masks, eye wear, gown, gloves) for all ECT staff (includes
recovery room).
3-ply facemask and gloves for nonclinical ECT staff interacting with
patients.
Decontamination of ECT room between batches of patients, and cleaning
work area with 70% ethanol.
Single use Mapleson C circuits for anaesthesia, disposable bite blocks, oral
airways and HEPA (high efficiency particulate air) filters.
Restrict numbers of ECT staff, others were redeployed.
Screening and temperature before patient entry.
Limit to one visitor with a face mask to accompany patient.
Batch patients (inpatient and/or outpatient), with decontamination and
PPE change between batches, with new operations board set up for
scheduling.
Increased from 7 to 8 ECT half-day sessions to maintain capacity.
PPE training sessions for ECT team, with audits.
Reduce ECT frequency when feasible.
ECT continued despite a case of COVID-19 in the inpatient unit, with
infection control procedures.
Continuously looking at sustainability of ECT operations with the
realization that the COVID-19 will not resolve quickly.

National Network of
Depression Centers
(NNDC), 202017
United States

Type of Article
Announcement

Letter
International Society for
ECT and Neurostimulation
(ISEN), 202018
United States

Group/Specialty

Aim/Purpose

NNDC is a network of
NNDC Urges Medical Officials to Consider ECT an
depression centers that
Essential Medical Service.
collaborate to advance
state-of-the-science in the
field of mood disorders.
ISEN is an international
To address concerns of ISEN
organization dedicated to
members and ECT profespromoting safe, ethical
sionals on how best to
and effective use of ECT
provide ECT services durand other brain stimulaing the crisis, and protion therapies for the
vides suggestions about
treatment of neuropsychi- practice adaptations.
atric illness through education and research.

ECT Practice Modifications













Tenenbein et al, 202019
Canada

Guidelines

University of Manitoba,
To provide guidelines for
Department of Anesthesiproviding ECT safely
ology, Perioperative &
while mitigating risks of
Pain Medicine, WRHA
COVID-19 transmission.
Anesthesia Program Anesthesia − Shared Health
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The Center for Medicare Services (CMS) recommendation to postpone nonessential surgeries and other procedures has constrained the use of ECT.
ECT is a vital, life-saving treatment that is nonelective and should be
maintained as essential, consistent with the CMS tiered approach of
providing treatment without delay when acuity is high.
ECT is a vital, and for some critical, treatment.
Caseload reduction to preserve manpower and resources requires triaging
and classifying each patient as elective, urgent/essential, or emergency.
COVID-19 screening process for patients and family members before and
on arrival for ECT.
Avoid ECT if COVID-19 positive or patient under investigation (PUI), unless
risk is imminent.
ECT for COVID-19 positive or PUI needs discussion regarding intubation
versus BMV, negative pressure room.
PPE includes gown, N95 mask, eye shield, head covering, gloves. N95 not
always required.
Essential staff only in treatment room.
Batching cases, e.g., outpatients before inpatients.
Staffing plan for ECT team members, scheduling, back-up and
contingencies to allow continued ECT service.
ECT is an aerosol generating medical procedure (AGMP).
Cautious selection of patients, reserve for those at high risk of psychiatric
deterioration without ECT.
M-ECT: previous treatment trials, lowest frequency, concurrent
pharmacologic treatments to increase intervals.
Acute ECT: alternative treatments.
No ECT if COVID-19 positive, under investigation, or under self-isolation or
monitoring.
Reduce volumes given increased time and PPE to deliver ECT.
Outpatient ECT only for exceptional
Circumstances and require prior approval.
Minimum number in treatment room.
PPE for all staff in treatment room includes gloves, level II gowns, eye
protection, N95 mask.
Ambu bag and/or anesthesia circuit with attached HEPA filter.
Minimum 3 minutes pre-oxygenation and BMV.
Treatment room door remains closed until 99% filtration has occurred,
additional HEPA filters can augment air changes per hour. Patients
transported to recovery after the required time has elapsed.
Shared Health Manitoba Algorithm for low risk operative procedures is
used to make decisions to treat ECT patient as COVID-19 suspects.

Electroconvulsive Therapy Practice Changes in Older Individuals Due to COVID-19
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Non-indexed
Author, Year

Lapid et al.

FIGURE 2. Electroconvulsive therapy during COVID-19 pandemic Perioperative considerations.

Source: Flexman AM, Abcejo AS, Avitsian R, et al. Neuroanesthesia Practice During the COVID-19 Pandemic: Recommendations From Society for Neuroscience in Anesthesiology and Critical Care (SNACC). J Neurosurg Anesthesiol. 2020;32(3):202-209. doi:10.1097/
ANA.0000000000000691

janitorial staff or housekeeping, gloves and procedure
masks are recommended, as well as limiting exposure
to the treatment rooms to before or after the treatments are completed. This means that the treatment
team personnel are responsible for sanitizing with
hospital-grade wipes between patients, including the
ECT machine, computer keyboards and/or mouse,
anesthesia machine, and any countertop. ECT personnel replace outer gloves, or change gloves and wash
hands, between each patient. Bite blocks, if used,
should be disposable. To protect the anesthesia
machine from being contaminated, a viral ﬁlter
should be used for each patient. At the time of supply
constraints, viral ﬁlters are placed in a paper bag,
labeled and stored for future use on the same patient.
Clustering Strategy: Outpatient and Inpatient ECT
ECT treatment facilities that serve both inpatients
and outpatients minimize patient-to-patient exposure
by allocating the different populations to different
treatment “clusters” or to different days, a practice
which greatly decreases the chance of cross-

Am J Geriatr Psychiatry 28:11, November 2020

contamination between groups during transport and
recovery. Inpatients can be further clustered by unit.
Some departments have also designated treatment
“teams” who alternate working certain shifts to further reduce risk of exposure.
ECT patient census is also impacted greatly by the
effects of COVID-19. As local incidence increases,
having a patient test positive on a psychiatric inpatient unit becomes more likely. A moratorium on
admissions for an inpatient unit thus leads to a lower
inpatient ECT census, which can further affect the
ability to schedule ECT for inpatients and outpatients
on separate days and may require services to operate
fewer days per week. Hospital administrations have
also pressured many sites to reduce operational days.
Although never ideal, sites have had to reduce
their current patient censuses - some by as much as
half − in order to accommodate reduced operations.
Reducing or altogether interrupting treatment can be
somewhat standardized with the use of a ﬂow chart
or algorithm, but ultimately this must be carefully
considered on a case-by-case basis. Important factors
to consider are the age of the patient, their location (i.
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e., are they currently in a nursing home or living independently), and the potential outcome of relapse.
When deciding whether or not to treat a patient during this time, a fundamental consideration is to weigh
the risk of exposure to a hospital setting and potentially infected asymptomatic staff and/or other
patients with the beneﬁt of avoiding a severe relapse
and admission to the emergency room.

CHANGES TO ECT PROCEDURES
Pre ECT
COVID screening is performed prior to each visit.
Screening questions include 1) Does the patient have
close contact with a person with a laboratory conﬁrmed case of COVID-19? 2) In the last 14 days, has
the patient experienced fever or new symptoms of
cough or shortness of breath, sore throat, diarrhea,
respiratory distress, chills, myalgias, loss of smell, or
change or loss of taste sensation.
If a patient is symptomatic, COVID-19 testing is
indicated. Whether to test asymptomatic patients
coming from a higher risk environment such as a
nursing home is dependent on several factors. If there
have been known cases or contacts, then testing is recommended. However, some facilities have been on
lockdown and have eliminated any contact between
clients, and others may refuse to test asymptomatic
individuals. Furthermore, state and federal guidelines
regarding testing continue to evolve based on availability and other factors, making these decisions more
complicated. Therefore, the decision to test an asymptomatic individual coming from a high-risk environment is case dependent but should be strongly
considered.

these supplies is often necessary due to shortages;
many sites are saving HEPA ﬁlters in biohazard bags
to be used again for the same patient.
Some sites have used pre-oxygenation to avoid
bagged mask ventilation (BMV) use during the procedure for appropriate patients.6 Pre-oxygenation is
done with a regular or non-rebreather mask (slight
difference between sites) for several minutes pretreatment, and then having the patients self-hyperventilate as they go off to sleep to try to minimize
BMV. While some patients still require BMV, it is
avoided as much as possible, which has the advantage of cutting down the risk of aerosolization, and
helps preserve HEPA ﬁlters.
Air recirculation
Given that BMV during ECT is an aerosol-generating procedure, facilities have revised the time interval
between ECT treatments based on factors such as the
size of ECT treatment rooms, capacity of the ventilation systems, air changes per hour in the building,
and location of exhaust vents. Determining the air
changes per hour or air circulation rate in the building
will help roughly calculate time to clear up most of
the room air and thereby the aerosols. The air circulation times can vary and are only estimates. Center for
Disease Control has guidelines that help calculate the
time required for air-borne contaminant removal by
efﬁciency. Close attention should be paid to the
assumptions in the tables provided in the appendices
of the guideline.7 A collaboration between engineering infection control departments can be helpful in
trying to determine a reasonable amount of time to
wait before bringing another patient into the room.
Some institutions have used two or more treatment
rooms and alternate between rooms to allow more air
recirculation between patients in each room. Obviously, this option is not available at many ECT sites.

During Treatment
Ventilation

Anesthesia

Masked ventilation causing aerosolization may be
the biggest risk to patients and staff in terms of potential exposure. The use of High Efﬁciency Particulate
Air (HEPA) ﬁlters for masked ventilation and anesthesia prevent the anesthesia machine itself from
becoming contaminated and exposing subsequent
patients. Although not an ideal practice, rationing of

Anesthetic dosing generally has remained
unchanged in response to the virus. However, some
sites have tried to keep succinylcholine doses at the
lower end of the safe range in order to allow for a
quicker return of spontaneous breathing after the seizure. This minimizes BMV overall, and in sites using
the preoxygenation and/or self-hyperventilation
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technique described above, may allow for the elimination of BMV altogether in some cases.
ECT titration
For newly-initiated acute courses of ECT, some
ECT psychiatrists continue the usual method of determining the seizure threshold, while others have
stopped the titration method to determine seizure
threshold. One method being used is starting at 100%
energy at the ﬁrst ECT, in order to minimize the time
a patient is not breathing since they are not being ventilated. Other methods include use of a prior stimulus
dose (if applicable) or an age-based approach. When
titration method is used to determine seizure threshold, other ECT providers use 6−12 times the seizure
threshold for subsequent ECT when using right unilateral placement.
Post ECT
Recovery room practice has not been dramatically
altered by the risk of COVID. However, recovery
nurses should wear eye protection and surgical
masks. Some sites felt that nurses working with
patients in immediate recovery should have N95
masks given the risk of exposure due to close contact
while patients may be coughing and emitting secretions. Patients who are coughing and not fully awake
should be allowed to recover in the treatment room
and be brought out only when they are not coughing.
As early as possible, before bringing the patient out of
the treatment room, a procedure mask should be correctly placed on the patient’s face. Patients should be
separated by at least 6 feet and/or physical barriers
such as partitions or curtains, if possible. Some sites
have shortened their stay requirement in the recovery
room or recovery lounge (if a 2-stage recovery) in
order to avoid crowding in these areas and maximize
social distancing.

have unfortunately become “hot spots” for the spread
of COVID-19.8 For this reason, ECT services have had
to be especially stringent when considering treating
older patients referred from LTC facilities − not only
due to the risk that an incoming patient may infect
ECT staff and other patients, but also the risk of rapid
spread to other vulnerable older adults if a patient
carries COVID-19 back to their LTC facility. It is paramount to involve the medical staff at the LTC facility
when weighing the pros and cons of treating these
patients. In places where pre-op testing is not readily
available, some ECT services have chosen to stop
accepting any geriatric patients or those coming from
LTC facilities.
Stopping ECT
Due to the COVID-19 crisis, many centers felt signiﬁcant pressure to quickly and dramatically reduce
the size of their ECT census. Given this, and the
increased mortality and morbidity risk of COVID-19
to geriatric patients, the decision regarding continuing ECT treatment, especially in the continuation or
maintenance phase requires a risk and/or beneﬁt
analysis. Treatment discontinuation, in some cases,
can result in dangerous relapse of symptoms that are
not well controlled by other means which could send
patients to the emergency room − an especially hazardous setting for a geriatric patient during this time.
Additionally, a full relapse can result in an inpatient
admission and the need for another acute course of
ECT, which both introduces additional risks to the
patient and utilizes more valuable resources. To avoid
this, clinicians are tapering down the frequency of
ECT treatments slowly while patients are closely
monitored by the primary psychiatric providers.
Close communication between the ECT service and
the outpatient treating psychiatrist is essential to
establish a safe treatment plan.
To Treat or Not to Treat

ECT OPERATIONS
Starting ECT
Nursing homes and other long-term care (LTC)
facilities for older adults are known to have high
transmission rates for infectious diseases, and thus
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In the US, it is clear across ECT practices that any
known COVID-19 positive patient, whether symptomatic or not, does not get treated with ECT unless it
is determined as life-saving for a life-threatening condition. In such rare cases, ECT should be administered in an operating room set-up with negative
pressure. However, in Belgium patients with COVID-
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19 continue to receive ECT with a special treatment
schedule,9 and a single case report in the UK
described successful ECT treatment of a patient with
severe catatonia who was ill with COVID-19.10
In patients who previously tested positive but are
now asymptomatic, the criteria for treating with ECT
are either 1) 2 weeks from being diagnosed and
3 days of being asymptomatic, or 2) 2 weeks of being
asymptomatic. The same criteria can be used for people who had symptoms suggestive of COVID-19 but
were never tested as the symptoms did not meet testing threshold. With all patients, 2 consecutive negative tests and no new exposure indicate it is safe to
proceed with ECT. For patients who test positive during a course of ECT, the decision to extend testing to
other patients is based on clinical indications and clinical judgment. These criteria vary by ECT practice.
Consent Issues
An important issue that is missing in the literature
is that of informed consent and disclosure of risks
related to COVID-19 transmission, which is particularly important in older adults who have increased
risk of more severe illness and morbidity from
COVID-19. Based on expert group discussions, there
is a consensus that the potential risk of COVID-19
transmission should be discussed with the patients
and the legal authorized representatives or substitute
decision-makers. Across all the ECT practice sites,
written consent forms for ECT have not been altered
to include speciﬁc COVID-19 wording, consistent
with all other practices that involve aerosol-generating procedures.

CONCLUSIONS
There is a clear and universal consensus that ECT
is a critical and essential treatment. In older adults,
ECT may be life saving for treatment resistant depression, depression with psychotic features, catatonia,

and severe agitation and aggression in individuals
with dementia. Reduction in the delivery of both
acute and maintenance ECT treatment for older
adults as a result of COVID-19 restrictions have
resulted in less effective treatment and greater relapse
of severe mood disorders and agitation in older
adults. Further, the clinical practice of ECT has rapidly changed as a consequence of the pandemic, and
approaches to mitigate infection transmission in the
setting of the COVID-19 are almost uniform across
the globe. Current testing for COVID-19 is limited by
testing equipment availability and treatment trials
and vaccine development are in very early stages of
development. Therefore, modiﬁcations to the practice
of ECT are likely to last for a substantial period of
time and may evolve further as the understanding
and treatment of COVID-19 and availability of PPE
improve. The community of clinicians involved in
neurotherapeutics must continue to collaborate, share
lessons learned and collect systematic outcome data
to ensure safe access to ECT administered with the
highest standards of infection mitigation.
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